Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial

4th May 09

Release Date: 04/05/2009 12:00am

Pharmaceutical company Pharmaxis (ASX:PXS, Nasdaq:PXSL) is pleased to announce positive results of its recently completed international Phase III trial of Bronchitol™ in people with cystic fibrosis. The study represents one of the largest clinical trials conducted in cystic fibrosis.

View PDF